Dermata Therapeutics Inc
dermatarx.comWhat Do They Do?
Develops cosmetic and over-the-counter skincare products for consumers, and Bioneedle-based topical skin-treatment technology for aestheticians and dermatologists.
10-K for FY2025, filed Mar 26, 2026We are a scientific leader in skincare, dedicated to the development and commercialization of products that address common and underserved…View ↗
We view this shift in consumer preferences as a significant benefit for our strategic repositioning. We have gained substantial clinical…View ↗
Our weekly Bioneedle treatment, aimed to help refine the appearance of a consumer’s skin, will be used alongside a daily salicylic acid…View ↗
In addition to the DTC channel for our products, we believe there is a market for our technology to aid in the intradermal delivery of…View ↗
We plan to leverage our Bioneedle platform for broad applicability across dermatologic and aesthetic skin conditions, potentially allowing…View ↗
How Do They Make Money?
No revenue reported yet.
10-K for FY2025, filed Mar 26, 2026
Who Are Their Customers?
Consumers are expected to buy through Dermata’s website; aestheticians, med spas and dermatologists can buy monthly kits for in-office treatments.
10-K for FY2025, filed Mar 26, 2026Successfully launch our first two commercial products, Tome Foundational Treatment and Tome Clearing Treatment. We are currently preparing…View ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 11, 2026
−$3MView ↗
- ▲ +74% (Loss)
- vs −$1.7M in Q2 FY2025
From drug candidates to skincare
The older report framed Dermata as a clinical-stage drug developer focused on prescription candidates; the latest describes plans for consumer and professional cosmetic and over-the-counter skincare, while continuing to explore Bioneedle delivery applications.
10-K for FY2022, filed Feb 21, 2023 10-K for FY2025, filed Mar 26, 2026We are a scientific leader in skincare, dedicated to the development and commercialization of products that address common and underserved…View ↗
We view this shift in consumer preferences as a significant benefit for our strategic repositioning. We have gained substantial clinical…View ↗
Our weekly Bioneedle treatment, aimed to help refine the appearance of a consumer’s skin, will be used alongside a daily salicylic acid…View ↗
We plan to leverage our Bioneedle platform for broad applicability across dermatologic and aesthetic skin conditions, potentially allowing…View ↗
Who Do They Compete With?
Competes with Neutrogena, Proactiv, Clean & Clear, PanOxyl, La Roche-Posay, CeraVe, Differin, Curology, Apostrophe, and Hims & Hers
10-K for FY2025, filed Mar 26, 2026The medical and aesthetic skin care markets in which we plan to sell our Tome skincare products are crowded with many small, medium, and…View ↗
Loading...
